封面
市场调查报告书
商品编码
1671948

免疫组织化学市场按产品、应用、最终用户和地区划分

Immunohistochemistry Market, By Product, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 142 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球免疫组织化学市场规模估计为 30.7 亿美元,预计到 2032 年将达到 48.4 亿美元,2025 年至 2032 年的复合年增长率为 6.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 30.7亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 6.70% 2032 年价值预测 48.4亿美元
数字。 2025 年免疫组织化学市场占有率(%),依地区划分
免疫组织化学市场-IMG1

免疫组织化学 (IHC) 是一种利用抗体特异性结合活组织中的抗原的原理来检测组织切片细胞中的抗原的技术。 IHC 可以识别细胞类型和生物标记的位置以及正常和患病组织中标靶抗原的分布,有助于疾病诊断、预后评估、预测医学和个人化医疗。 IHC 利用抗体-抗原亲和性在显微镜下观察组织样本中细胞内的特定蛋白质,有助于细胞类型辨识和生物分子定位。为了获得准确、可重复的结果,必须严格控制所使用的细胞、抗原和抗体。

市场动态:

全球免疫组织化学市场主要受老年人口增加以及相关慢性病和感染疾病病率上升的推动。根据世界卫生组织(WHO)2022年10月的报告,2015年至2050年间,全球60岁及以上人口比例将成长近一倍,从12%增至22%。全球癌症发生率的不断上升也推动了对 IHC 检测的需求,以检测与癌症诊断和预后相关的生物标记。然而,IHC 诊断试剂套件核准的严格法律规范和熟练人力的短缺(尤其是在新兴国家)是限制市场成长的挑战。数位病理学解决方案的出现提供了 IHC 染色的自动量化以及人工智慧的整合以实现更准确的分析,为市场参与者提供了有利可图的机会。

本研究的主要特点

  • 本研究报告对全球免疫组织化学市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032)的市场规模和年复合成长率(CAGR%)。
  • 它揭示了不同领域的潜在收益成长机会,并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球免疫组织化学市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球免疫组织化学市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球免疫组织化学市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 市场机会
  • 影响分析
  • 管道分析
  • PEST分析
  • 监管情景
  • 市场趋势
  • 主要亮点
  • 合併和收购

4. 全球免疫组织化学市场 - COVID-19 疫情的影响

  • 经济影响
  • 对临床试验的影响
  • 政府倡议

5. 2020 年至 2032 年全球免疫组织化学市场(依产品划分)

  • 抗体
  • 一抗
  • 二抗
  • 试剂
  • 蛋白水解酶
  • 固定试剂
  • 组织学染色
  • 冲淡
  • 其他的
  • 装置
  • 玻片染色系统
  • 组织处理系统
  • 幻灯片扫描仪
  • 其他设备
  • 套件

6. 2020 年至 2032 年全球免疫组织化学市场(按应用划分)

  • 诊断
  • 癌症
  • 感染疾病
  • 自体免疫疾病
  • 神经系统疾病
  • 其他疾病
  • 研究
  • 其他的

7. 2020 年至 2032 年全球免疫组织化学市场(依最终使用者划分)

  • 医院
  • 诊断实验室
  • 学术研究所
  • 其他的

8. 2020 年至 2032 年全球免疫组织化学市场(按地区划分)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 热图分析
  • 市场占有率分析
    • Merck KGaA
    • Rockland Immunochemical, Inc.
    • F. Hoffman-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam plc.
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

第 10 章 分析师观点

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4795

Global Immunohistochemistry Market is estimated to be valued at USD 3.07 Bn in 2025 and is expected to reach USD 4.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.70% 2032 Value Projection: USD 4.84 Bn
Figure. Immunohistochemistry Market Share (%), By Region 2025
Immunohistochemistry Market - IMG1

Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC enables researchers to identify cell types and locations of biomarkers as well as the distribution of target antigens in normal and diseased tissues. It helps in disease diagnosis, prognostic evaluation, and predictive and personalized medicine. IHC uses affinity between antibodies and antigens for making specific proteins in cells of a tissue sample visible microscopically, thus aiding in the identification of cell type and localization of biomolecules. The cells, antigens, and antibodies used must be carefully controlled to ensure accurate and reproducible results.

Market Dynamics:

The global immunohistochemistry market is primarily driven by the rising geriatric population and associated increase in prevalence of chronic and infectious diseases. According to the World Health Organization (WHO) October 2022 report, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. The growing incidence of cancer worldwide is also boosting the demand for IHC assays to detect biomarkers related to cancer diagnosis and prognosis. However, stringent regulatory frameworks for the approval of IHC diagnostic kits and lack of skilled personnel especially in developing nations are some challenges restraining the market growth. The emergence of digital pathology solutions offering automated quantification of IHC staining and integration of Artificial Intelligence for more accurate analysis present lucrative opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global immunohistochemistry market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunohistochemistry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market.

Market Segmentation

  • Product:
    • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • Reagents
    • Proteolytic Enzymes
    • Fixation Reagents
    • Histological Stains
    • Diluents
    • Others
    • Equipment
    • Slide-staining systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
    • Kits
  • Application:
    • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Neurological Diseases
    • Others Diseases
    • Research
    • Others
  • End User:
    • Hospitals
    • Diagnostics Laboratories
    • Academic & Research Institutes
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck KGaA
    • Rockland Immunochemicals Inc.
    • Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Bio-Rad Laboratories Inc.
    • Cell Signaling Technology Inc.
    • Bio SB
    • Agilent Technologies Inc.
    • Abcam plc.
    • Becton Dickinson and Company
    • Miltenyi Biotec
    • Biocare Medical LLC
    • Eagle Biosciences Inc.
    • Bio-Techne
    • Diagnostic Biosystems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Mergers & Acquisitions

4. Global Immunohistochemistry Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials
  • Government Initiatives

5. Global Immunohistochemistry Market, By Product Type, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Primary Antibodies
  • Secondary Antibodies
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Proteolytic Enzymes
  • Fixation Reagents
  • Histological Stains
  • Diluents
  • Others
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Slide-staining systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

6. Global Immunohistochemistry Market, By Application, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Others Diseases
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

7. Global Immunohistochemistry Market, By End User, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

8. Global Immunohistochemistry Market, By Region, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • North America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD BN)
      • South Africa
      • Central Africa
      • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Merck KGaA
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rockland Immunochemical, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • F. Hoffman-La Roche Ltd
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cell Signaling Technology, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio SB
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Abcam plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact